News, Analysis & Insights on Nutrition, Supplements, and Health
China’s nicotinamide mononucleotide (NMN) supplier EffePharm is embarking on its first human clinical trial as it seeks to validate the anti-ageing effects and safety of its ingredient “Uthever”.
Gencor Pacific is embarking on a human trial in Australia to validate the immunity boosting ability of Palmitoylethanolamide (PEA) against the backdrop of the rising demand for immunity supplements amid the worldwide spread of COVID-19.
This round-up focuses on the vitamin C sales surge in China due to COVID-19, the addition of three 'blue-hat' probiotics formulation to Sirio Pharma and more.